STAT | Reporting from the frontiers of health and medicine 中文 关注 STAT+：Capricor Therapeutics 的杜氏肌营养不良症疗法正面临 FDA 拒批” Capricor Therapeutics 正努力避免其针对杜氏肌营养不良症的细胞疗法被 FDA 拒收。 STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection statnews.com STAT | Reporting from the frontiers of health and medicine 中文 RSS thenote.app
